212 related articles for article (PubMed ID: 22820531)
1. Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles.
Peer D
Adv Drug Deliv Rev; 2012 Dec; 64(15):1738-48. PubMed ID: 22820531
[TBL] [Abstract][Full Text] [Related]
2. Altering the immune response with lipid-based nanoparticles.
Landesman-Milo D; Peer D
J Control Release; 2012 Jul; 161(2):600-8. PubMed ID: 22230342
[TBL] [Abstract][Full Text] [Related]
3. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
4. Drug targeting using solid lipid nanoparticles.
Rostami E; Kashanian S; Azandaryani AH; Faramarzi H; Dolatabadi JE; Omidfar K
Chem Phys Lipids; 2014 Jul; 181():56-61. PubMed ID: 24717692
[TBL] [Abstract][Full Text] [Related]
5. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases.
Wang G; Mostafa NZ; Incani V; Kucharski C; Uludağ H
J Biomed Mater Res A; 2012 Mar; 100(3):684-93. PubMed ID: 22213565
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
Battaglia L; Gallarate M
Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
[TBL] [Abstract][Full Text] [Related]
8. Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach.
Solmesky LJ; Shuman M; Goldsmith M; Weil M; Peer D
Nanotechnology; 2011 Dec; 22(49):494016. PubMed ID: 22101838
[TBL] [Abstract][Full Text] [Related]
9. Porous nanoparticles in drug delivery systems.
Arayne MS; Sultana N
Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
[TBL] [Abstract][Full Text] [Related]
10. Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.
Ramishetti S; Landesman-Milo D; Peer D
J Drug Target; 2016 Nov; 24(9):780-786. PubMed ID: 27030014
[TBL] [Abstract][Full Text] [Related]
11. SiRNA delivery: challenges and role of carrier systems.
Shegokar R; Al Shaal L; Mishra PR
Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
[TBL] [Abstract][Full Text] [Related]
12. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
Cheng X; Lee RJ
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
[TBL] [Abstract][Full Text] [Related]
13. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
14. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes.
Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M
Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966
[TBL] [Abstract][Full Text] [Related]
15. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
[TBL] [Abstract][Full Text] [Related]
16. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
Simovic S; Barnes TJ; Tan A; Prestidge CA
Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
[TBL] [Abstract][Full Text] [Related]
17. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery.
Nishiyama N; Kataoka K
Pharmacol Ther; 2006 Dec; 112(3):630-48. PubMed ID: 16815554
[TBL] [Abstract][Full Text] [Related]
18. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.
Abdel-Mottaleb MM; Lamprecht A
Drug Dev Ind Pharm; 2011 Feb; 37(2):178-84. PubMed ID: 21073322
[TBL] [Abstract][Full Text] [Related]
19. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.
Xiong XB; Falamarzian A; Garg SM; Lavasanifar A
J Control Release; 2011 Oct; 155(2):248-61. PubMed ID: 21621570
[TBL] [Abstract][Full Text] [Related]
20. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
Constantinides PP; Chaubal MV; Shorr R
Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
